Pnc Financial Services Group, Inc. Halozyme Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 9,708 shares of HALO stock, worth $554,326. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,708
Previous 10,061
3.51%
Holding current value
$554,326
Previous $575,000
19.3%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding HALO
# of Institutions
536Shares Held
123MCall Options Held
294KPut Options Held
169K-
Black Rock Inc. New York, NY17.6MShares$1.01 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$736 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$379 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$232 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$195 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.95B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...